Intracranial Pressure Monitors Market Expected to Reach USD 350.5 Million Globally in 2023

According to a new market report published by Transparency Market Research “Intracranial Pressure Monitors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”, the global intracranial pressure monitors market was valued at USD 210.5 million in 2014 and is projected to expand at a CAGR of 6.4% from 2015 to 2023 to reach USD 350.5 million in 2023.

Intracranial pressure monitors are medical devices used to measure the pressure inside the skull under critical care. Factors such as increasing incidence of neurological and cerebrovascular disorders, coupled with growing awareness regarding the application of intracranial pressure monitors have fueled the growth of the intracranial pressure monitors market. Increasing incidence of traumatic head injuries worldwide is another factor likely to drive the growth of the intracranial pressure monitors market during the forecast period from 2015 to 2023.

Browse Full Report: http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html

Among the product variants available in the market, the external ventricular drain (EVD) segment accounted for the largest share (over 35%) of the intracranial pressure monitors market in 2014, as these devices are extremely affordable, and easy-to-use. In addition, the transducer of EVD can be re-zeroed at any point of time, driving the demand for these devices. However, the air pouch devices are anticipated to expand at the fastest CAGR due to the accurate measurements and the lowest zero-drift characteristics offered by these devices. In addition, increasing rate of traumatic brain injuries demands greater technological advancement and accuracy, which contributes towards the high growth rate of the air pouch devices market.

Based on application, the traumatic brain injury segment held the largest share of the market in 2014 due to increasing incidence of violence, traffic-related accidents, and sport injuries. The segment is also anticipated to grow at the highest CAGR due to technologically advanced diagnostic platform offered by intracranial pressure monitors. Similarly, based on end-user, the trauma centers segment held the largest market share in the global intracranial pressure monitors market. Round the clock availability of specially trained health care experts and increasing number of critically ill patients is driving the growth of trauma centers market segment. The segment is also expected to progress at the fastest CAGR in order to cater to the demands of severely injured patients for better quality outcomes.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6445

In terms of regional market analysis, North America accounted for the largest share (over 50%) of the global intracranial pressure monitors market in 2014. High awareness, well developed healthcare infrastructure, and high acceptance of technologically advanced monitoring equipment are contributing towards North America’s relatively higher market share compared to Europe, Asia Pacific, and RoW. However, countries in Asia Pacific such as Japan, South Korea, Australia, Malaysia, India, and China are witnessing remarkable growth. Large number of population suffering from cerebrovascular diseases such as traumatic brain injury, intracerebral hemorrhage, and subarachnoid hemorrhage, coupled with easy market penetration in developing countries would augment the growth of the intracranial pressure monitors market in Asia Pacific.

The global intracranial pressure monitors market exhibits intense competition among the existing players. The market is fragmented, characterized by the presence of both established as well as emerging companies. Major players operating in the intracranial pressure monitors market are Codman & Shurtleff, Inc., Haiying Medical, HeadSense Medical, Inc., Integra LifeSciences Corporation, Medtronic, Inc., Raumedic AG, SOPHYSA, and Spiegelberg GmbH & Co. KG. 

Browse the full Intracranial Pressure Monitors Market (Type: External Ventricular Drain, Fiberoptic Monitors, Strain Gauge Transducers, and Air Pouch Devices; Application: Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, Subarachnoid Hemorrhage, and Others; End-user: Trauma Centers and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023 report at http://www.transparencymarketresearch.com/intracranial-pressure-monitors-market.html

The global intracranial pressure monitors market has been segmented as follows:

Intracranial Pressure Monitors Market, by Type

• External Ventricular Drain
• Fiberoptic Monitors
• Strain Gauge Transducers
• Air Pouch Devices

Intracranial Pressure Monitors Market, by Application

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Subarachnoid Hemorrhage
• Others

Intracranial Pressure Monitors Market, by End-user

• Trauma Centers
• Hospitals

Intracranial Pressure Monitors Market, by Geography

• North America
• Europe
• Asia Pacific (APAC)
• Rest of the World (RoW)

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. 

High Prevalence of Diabetes and Chronic Kidney Disorders to Drive Dialysis Products and Services Market

A recent study by Transparency Market Research (TMR) forecasts that the global dialysis products and services market will grow at a CAGR of 5.9% between 2014 and 2020. TMR, a market intelligence firm based in the United States, in its report states, that the global dialysis products and services market will reach a market value worth US$115474.9 million by 2020 from US$77607.7 million in 2013. The report titled ‘Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020’ is available for sale on the website. The TMR report identifies that the rising incidence of renal disorders and related conditions amongst the aging population has a significant impact on the overall demand for dialysis products and services. Government reimbursement policies for dialysis procedures and high incidence of diabetes and chronic kidney diseases are the other factors that drive the global dialysis products and services market.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/dialysis-products-services-market.htm

The high incidence of kidney diseases can be attributed to inactive lifestyles, stress, smoking, and alcohol consumption. Dialysis as a life sustaining process, involves blood purification in patients affected by renal disorders. It removes the extra fluids and waste products from the blood and also controls the other fluidic levels in the patients’ body.According to the report, the global dialysis products and services market is segmented on the basis of product, service, and geography. Based on product, this market is categorized into hemodialysis products and peritoneal dialysis products. With a market share of almost 31%, the segment for hemodialysis machines held the highest share in the overall market for hemodialysis products in 2013.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3026

The pressing need to adopt sophisticated treatment for chronic kidney diseases and rising incidence of renal disorders stimulates the demand for hemodialysis machines. Within the segment for peritoneal dialysis products, dialysates/concentrates occupy the highest market share. Surging demand for peritoneal dialysis fuels the demand for dialysates. On the basis of service, the global dialysis products and services market is segmented into home dialysis and in-center dialysis. Expansion of the segment for in-center dialysis can be attributed to the convenience in administering the course of treatment by skilled dialysis specialists in a regularized schedule. Geographically, this research report classifies the global dialysis products and services market into Asia Pacific, Europe, North America, and Rest of the World. In 2013, North America held the highest share in the global dialysis products and services market owing to widespread awareness about the treatment options and an increasing patient pool requiring dialysis. Some of the Asia Pacific economies such as India, Brazil, China, and Japan will prove to be potential markets in the forthcoming years owing to increasing income levels, greater government support for developing better healthcare infrastructure, and favorable reimbursement policies.

Browse the full Dialysis Products and Services Market [Hemodialysis Products, Peritoneal Dialysis Products; In-center Dialysis Services and Home Dialysis Services] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/dialysis-products-services-market.html

It is anticipated that the robustly growing dialysis products and services market will give a significant boost to the global pharmaceuticals market during the forecast period.
The prominent companies operating in the global dialysis products and services market are Rockwell Medical Technologies Inc., NxStage Medical Inc., Nipro Corporation, Nikkiso Co. Ltd., Medical Components Inc., and Covidien plc.

High Incidence of Coronary Artery Disease Worldwide to Propel Interventional Cardiology Devices Market

A new report has been published by Transparency Market Research, titled “Interventional Cardiology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022”. TMR, a market intelligence company based in the U.S., states that the global interventional cardiology devices market was estimated at US$8.7 billion in 2013, is expanding at a CAGR of 2.9% from 2014 to 2022, and is predicted to reach US$11.2 billion in 2022.As per the TMR report, it was about 50 years ago that coronary artery bypass surgery (CABG) was developed for treating multi-vessel coronary artery disease (CAD) and complex ischemia. Interventional cardiology is defined as a minimally invasive catheter-based technology and minimally invasive surgeries have several benefits such as reduced cost, shorter hospital stay, minimal incision, shorter recovery time, and less post-surgical complications. These benefits are helping growth of the interventional cardiology devices market.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/interventional-cardiology-devices.htm

According to this TMR report, on the basis of device type, the global market for interventional cardiology devices market is segmented into: catheters, stents, percutaneous transluminal coronary angioplasty (PTCA) guide wires, percutaneous transluminal coronary angioplasty (PTCA) balloons, and others.Amongst these, the biggest share was held by the stents segment. Stents are further bifurcated into drug eluting stents, bare metal stents, and bioabsorbable vascular stents. Amongst these, in 2014, the drug eluting stents held the biggest market share in the global market for interventional cardiology devices and is set to govern the market through the forecasting horizon.The TMR report states that the increasing incidence of coronary artery diseases and increasing geriatric population are amongst the major reasons stimulating the development of the global interventional cardiology market. Rising incidence of factors such as obesity, smoking, and dietary irregularities are responsible for the rising prevalence of cardiac artery diseases.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=853

Nonetheless, CABG procedures are experiencing a decline because of the evolution of interventional techniques, as per the studies directed by the NCBI. In Europe, CAD is responsible for about 1.9 million deaths every year, of which more than 400,000 are premature deaths. Thus, the disease is a key cause of premature deaths in Europe. Therefore, the increased occurrence of coronary artery diseases will rise demand for percutaneous coronary interventions, which would boost the development of the market for interventional cardiology devices.As per this TMR research report, this market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and North Africa, and Rest of the World (RoW). North America led the market for global interventional cardiology devices, trailed by Europe, due to the consistent implementation of drug eluting stents, which are premium priced.

Asia Pacific stood as the third biggest market for interventional cardiology devices. This region is predicted to record the highest CAGR through the forecasting horizon. Developing healthcare infrastructure and rising occurrence of coronary artery disease will stimulate the development of this market in the region.Key players in the interventional cardiology devices market include Cordis Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, St. Jude Medical, Inc., Medtronic, plc, Terumo Medical Corporation, and Smiths Medical.

Browse the full Interventional Cardiology Devices Market: (By Types: Stents, Catheters, PTCA Balloons, PTCA Guidewires, Imaging Systems and Others): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 report at http://www.transparencymarketresearch.com/interventional-cardiology-devices.html

Telemedicine Industry Players to Benefit from the Untapped Rural Market

Transparency Market Research has recently published a new market study titled “Telemedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”. According to this research study, the global telemedicine market was worth US$14.3 billion in 2014.Growing at a marked 14.3% CAGR during the forecast period from 2014 to 2020, the global telemedicine market is anticipated to reach US$36.3 billion by 2020. It is no wonder that the global telemedicine market will more than double its value in the forecast period. Telemedicine is more beneficial than traditional healthcare technology as it employs telecommunication technology to deliver patients and practitioners the convenience of location, time, and cost. According to the Pennsylvania Homecare Association, telemonitoring decreased hospitalizations by a massive 75% and ER visits by 83%.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/telemedicine-market.htm

Other market forces such as growing demand for personal healthcare, increasing demand for privacy key for usage of telemedicine, and the accelerating government spending and reimbursement policies are further driving the global telemedicine market. However, factors such as the shortage of dedicated medical staff and delayed response time will suppress the global telemedicine market. Moreover, the incomplete/inadequate assessment being reported by some patients and practitioners might also restrain the global telemedicine market.Nonetheless, the players operating in the global telemedicine market are tapping on the opportunity of proliferation of mobile telecommunication technology to drive the coverage of patient pool in rural markets. The key players operating in the global telemedicine market are Philips Healthcare, Polycom, OBS Medical, In Touch Technologies, Honeywell HomMed, Cisco Systems, CARDIOCOM, AMD Global Telemedicine, and Allscripts Healthcare Solutions.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

On the basis of specialty, the global telemedicine market is segmented into neurology, dermatology, cardiology, emergency care, orthopedics, internal medicine, gynecology, and others. In 2013, the dermatology segment held the largest market revenue of US$2.0 billion. However, according to a TMR analyst the neurology segment will demonstrate the highest CAGR of 15.9% during the forecasting horizon, due to the large number of Parkinsons and Alzheimer diseases.By service-type, the global telemedicine market is divided into tele-monitoring, tele-consultation, tele-education, tele-training, tele-care, and tele-surgery. Among these sectors, the tele-consultation sector generated the largest revenue in 2013. Around the world, medical consultation services are the most common type of telemedicine used for differential diagnosis consultation by physicians. On the other hand, the highest growth was demonstrated by the tele-monitoring segment. This can be attributed to the accelerating number of diabetic and disability patients globally.

Browse the full Telemedicine Market (Specialty, Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Internal Medicine, Gynecology, and Others) and Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Training, Tele-Care, and Tele-Surgery) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/telemedicine-market.html

Geographically, the global telemedicine market is dominated by North America. However, it is anticipated that Asia Pacific will expand at the fastest CAGR of more than 16% during the forecast period.

Fracture Fixation Products Market Trends And Forecast 2015 - 2023

Fracture fixation is a process of stabilizing the fractured bone, to enable fast healing of the injured bone, and to return early mobility and full function of the injured extremity. The global fracture fixation market is growing significantly due to the rise in prevalence of osteoporosis and osteoarthritis propelling the demand for joint replacement surgeries. Osteoporosis is an alarming health issue, especially in the geriatric population. The disease is associated with weakening of hip, knee, wrist, and spinal bones and joints. According to estimates provided by the International Osteoporosis Foundation, 75 million patients are diagnosed with osteoporosis in Europe, the U.S., and Japan every year. Moreover, consistent increase in the orthopedic procedures due to rise in geriatric population and obesity would directly boost the demand for fracture fixation devices. Road accidents, sports injuries and violence are the major driving factors for the global fracture fixation products market. However, frequent product recalls would restrict the fracture fixation products market growth during the focus period.

Browse Full Report: http://www.transparencymarketresearch.com/fracture-fixation-products-market.html

The global fracture fixation products market has been categorized as internal fracture fixation products and external fracture fixation products. The application of these devices is mainly based on the type of injury. Internal fracture fixation devices involve surgical implementation of implants that aid in bone repair whereas external fracture fixation devices are used to stabilize bone and soft tissues with minimum invasion. The internal fracture fixation products segment dominated the osteosynthesis devices market due to factors such as increased life expectancy, high prevalence of osteoporosis, and rising cases of road accidents and sports injuries. The internal fracture fixation products are categorized into a major segments such as wires and pins, screws and plates, and intramedullary nails or rods. Screws and plates held the largest market in the internal fracture fixation products due to its multi-utility. Majorly employed external fixation products include Hoffman devices, Ilizarov devices along with clamps, frames, and pins.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6233

Geographically, the global osteosynthesis devices market has been segmented into five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Rest of the World (RoW). North America held the largest share of the global fracture fixation products market followed by Europe. North America is anticipated to continue its dominance during the forecast period due to the presence of major players headquartered in this region. Additionally, technological advancements, low cost/utility ratio, increasing health care investments and growing geriatric population are supporting the growth of fracture fixation products market. The fracture fixation products market in Europe is primarily driven by Germany, the U.K., and France. Despite premium pricing, innovative products are gaining market share in Europe. Asia Pacific has been identified as the most lucrative market. . Presence of large population, increasing disposable income, and growing patient awareness are some of the factors driving the market in Asia Pacific. The fracture fixation products market in Latin America is anticipated to be largely driven by favorable demographics, high number of motor vehicle accidents, and improving access to health care, which will allow more patients to undergo these procedures. Improving insurance coverage across Latin America and introduction of universal health care facilities in Brazil, Mexico and Columbia will help better accessibility of these services to the patients.

Some of the major players operating in this market include DePuy Synthes Companies, Stryker Corporation, Zimmer Biomet Holdings, Smith & Nephew, Aesculap, Inc. and Néosteo SAS and others.

Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

According to a new market report published by Transparency Market Research Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023, the global bone grafts and substitutes market was valued at USD 2.35 billion in 2014 and is anticipated to expand at a CAGR of 4.5% from 2015 to 2023 to reach USD 3.48 billion in 2023.

Bones have the natural ability to heal, but if the defects surpass a critical size, then surgical intervention is often required to regenerate the bone. Hence, presently, various bone grafts and substitutes are available to regenerate the bone. According to the American Academy of Orthopaedic Surgeons, the ideal bone graft substitute (BGS) is biocompatible, easy to use, osteoinductive, osteoconductive, structurally similar to bone, and cost effective. Factors such as rapid technological changes from autografts to allografts and penetration of synthetic and tissue engineered bone grafts in the market are propelling the growth of the bone grafts and substitutes market. Moreover, increasing demand from customers and rising industry standards are spurring the growth of the global bone grafts and substitutes market. Additionally, according to the International Osteoporosis Foundation, worldwide incidence of fracture is anticipated to increase by 240% in women and 310% in men by 2050. Thus, these factors are expected to drive the global bone grafts and substitutes market during the forecast period from 2015 to 2023.

Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/bone-grafts-substitutes-market.htm

The global bone grafts and substitutes (BGS) market has been categorized into allografts and bone graft substitutes. The allografts segment includes demineralized bone matrix (DBM) and other allografts (freeze-dried bone and fresh frozen bone). The bone graft substitutes segment has been further classified into synthetic bone grafts, bone morphogenetic protein (BMP), and others.

Allograft is a tissue graft which is received from a donor of the same species; it is not genetically identical as an autograft. Allografts possess both osteoinductive and osteoconductive properties, and hence serve as a substitute for autografts. Ready availability of allografts in various shapes and sizes that can be processed in various forms such as chips and others as per requirement is likely to be one of the major factors fueling the growth of the allografts segment during the forecast period from 2015 to 2023. In the U.S., approximately one third of bone graft procedures use allografts, however risk of infection transmission is associated with its usage. Therefore, in order to minimize the risk of diseases transmission, allograft tissue is treated with several techniques such as tissue freezing, freeze drying, and sterilization. Thus, these factors collectively propel the growth of the allografts segment. The allografts segment is anticipated to reach USD 1,148.0 million in 2023 at a CAGR of 3.9% during the forecast period from 2015 to 2023.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6200

Bone graft substitutes is the fastest growing segment of the global bone grafts and substitutes market. The bone graft substitutes segment comprises synthetic bone grafts, bone morphogenetic proteins (BMP), and others. Factors such as increasing procedural volume of spinal fusion and joint reconstruction due to rising geriatric population and launch of innovative products are the major factors supporting the growth of this segment. Bone morphogenetic proteins (BMP) accounted for the largest share of around 34% of the bone graft substitutes segment in 2014. BMPs are a group of growth factors that play a significant role in bone induction, regulation, and repair. Technological advances in biochemical techniques and research and development has led to the introduction of two FDA-approved commercial products named rhBMP-2 (INFUSE by Medtronic plc) and rhBMP-7 (OP-1 by Stryker). Growth of the BMP segment is primarily driven by advantages over allograft tissues, which present a potential risk of disease transmission, morbidity, and availability issues, and high cost of commercially available BMP products.

Bone grafts and substitutes are used in various application areas such as spinal fusion, foot and ankle, long bone, dental, joint reconstruction, and craniomaxillofacial procedures. Allografts are majorly used for the treatment of joint reconstruction, spinal, trauma, craniomaxillofacial, and dental procedures. Synthetic bone grafts are majorly used in long bone and spinal fusion procedures. The spinal fusion application segment dominated the global bone grafts and substitutes market in 2014 due to rising geriatric population and increasing global demand for minimally invasive surgeries. However, rising preference for stem cell therapy and other growth factors such as platelet derived factors could hamper the growth of the BGS market during the forecast period.

Key players operating in the global bone grafts and substitutes market include AlloSource, Medtronic plc, Stryker Corporation, Baxter International, DePuy Synthes, Nuvasive, Inc., Wright Medical Group, Zimmer, Inc., and Orthofix Holdings, Inc.

Browse the full Bone Grafts and Substitutes Market (By Type: Allografts, and Bone Graft Substitutes; By Application: Spinal Fusion, Long Bone, Foot and Ankle, Craniomaxillofacial, Joint Reconstruction, and Dental) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/bone-grafts-substitutes-market.html

Global Postpartum Hemorrhage Treatment Devices Market to reach USD 926.1 million in 2023

According to a new market report published by Transparency Market Research “Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast, 2015 - 2023”, the global postpartum hemorrhage treatment devices market was valued at USD 604.4 million in 2014 and is estimated to reach USD 926.1 million in 2023, expanding at a CAGR of 4.9% from 2015 to 2023.According to the World Health Organization (WHO), postpartum hemorrhage (PPH) is the principal cause of maternal mortality, accounting for more than 30% of all maternal deaths in developed as well as developing countries. This condition can be defined as blood loss in excess of 500 mL after vaginal delivery or more than 1,000 mL after cesarean delivery. Moreover, if such blood loss occurs within 24 hours of delivery, it is categorized as early or primary PPH. If such blood loss occurs after 24 hours of delivery, it is termed as late or secondary PPH. The organization also stated that more than 14 million women suffer from PPH globally each year, of these 150,000 women die annually.

Browse Full Report: http://www.transparencymarketresearch.com/pressrelease/postpartum-hemorrhage-treatment-devices-market.htm

Major factors likely to boost the growth of the market are high prevalence of PPH in various countries, growing number of educational and training initiatives by governments, and escalating risk factors related to PPH. However, lack of product awareness in the emerging economies and low acceptance of unconventional preventive devices would hamper the growth of the postpartum hemorrhage treatment devices market during the forecast period.

Non-pneumatic anti-shock garment (NASG), Uniject prefilled injection system, and uterine balloon tamponade collectively form the postpartum hemorrhage treatment devices market. The uterine balloon tamponade segment has been sub-segmented into Foley catheters, condom catheters, and others. Uterine balloon tamponade was the largest segment of the PPH treatment devices market, accounting for approximately 46.3% share in 2014. The segment is expected to maintain its leadership position during the forecast period. Factors such as ultra-low cost, easy availability, and high effectiveness have been attributed to the largest share of the uterine balloon tamponade segment. In addition, several public health organizations such as the International Confederation of Midwives (ICM), the American College of Obstetricians and Gynecologists, and the World Health Organization (WHO) recognize UBT devices as an ultra-affordable medical alternative that could significantly help in the management of PPH in resource-poor health care settings where pharmaceutical and surgical interventions are not readily available.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164

Key organizations studied and profiled in this study include Cook Medical, Inc., Teleflex Incorporated, C. R. Bard, Inc., 3rd Stone Design, Inc., Bactiguard AB, Program for Appropriate Technology in Health (PATH), Utah Medical Products, Inc., and ZOEX NIASG. These players also collaborate with health care facilities, maternal clinics, and various other organizations through long-term agreements in order to provide innovative preventive PPH treatment devices. This, in turn, helps them to strengthen their market position and subsequently experience rapid growth.

Browse the full Postpartum Hemorrhage (PPH) Treatment Devices Market (Product Type: NASG, Uniject Prefilled Injection System, Uterine Balloon Tamponade (Foley Catheters, Condom Catheters and Others) - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html

The global postpartum hemorrhage treatment devices market has been segmented into the following categories:

Postpartum Hemorrhage (PPH) Treatment Devices Market, by Products

• Non-pneumatic Anti-shock Garment (NASG)
• Uniject Prefilled Injection System
• Uterine Balloon Tamponade
  • Foley Catheters
  • Condom Catheters
  • Others

Postpartum Hemorrhage (PPH) Treatment Devices Market, by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • Rest of Asia Pacific
• Latin America (LATAM)
• Middle East & North Africa (MENA)
• Rest of the World

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.